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Prolonged selective breeding of Hsd:ICR mice for high levels
of voluntary wheel running has favored an unusual
phenotype (mini-muscle [MM]), apparently caused by
a single Mendelian recessive allele, in which hindlimb muscle
mass is reduced by almost 50%. We recently described the
creation and phenotypic characterization of a population
suitable for mapping the genomic location of the MM gene.
Specifically, we crossed females from a high-runner line
fixed for the MM allele with male C57BL/6J. F1 males were
then backcrossed to the MM parent females. Backcross
(BC) mice exhibited a 50:50 ratio of normal to MM
phenotypes. Here, we report on linkage mapping of MM in
this BC population to a 2.6335-Mb interval on MMU11. This
region harbors ;100 expressed or predicted genes, many
of which have known roles in muscle development and/or
function. Identification of the genetic variation that underlies
MM could potentially be very important in understanding
both normal muscle function and disregulation of muscle
physiology leading to disease.
Prolonged selective breeding of Hsd:ICR mice for high
levels of voluntary wheel running has favored an unusual
phenotype (mini-muscle [MM]), apparently caused by
a single Mendelian recessive allele, in which hindlimb
muscle mass is reduced by almost 50%. This phenotype was
originally observed in 2 of 4 replicate selected lines (termed
HR for high runner) and in 1 of 4 control (nonselected) lines
(Garland et al. 2002). Analyses of data from the first 22
generations of the selection experiment indicated that the
mutant allele was present at a frequency of approximately
7% in the base population (outbred Hsd:ICR mice). Five of
the 8 total lines apparently lost the allele by random genetic
drift. In one control line, the phenotype, representing
homozygotes, was observed at a frequency of 0–10% for the
first 22 generations (Garland et al. 2002) and was then
apparently lost (T Garland Jr. unpublished observations).
The 2 selected lines that have exhibited the phenotype
showed an increase in frequency consistent with positive
selection (Garland et al. 2002). In one (lab designated line 6),
the phenotype remains polymorphic as of generation 50. In
the other (lab designated line 3), the mutation apparently
had gone to fixation by generation 36 (Syme et al. 2005).
The most characteristic phenotype of MM allele
homozygotes is a 50% reduction in mass of the triceps
surae muscle complex (Garland et al. 2002) as well as in
mass of mixed hindlimb muscle exclusive of the triceps
surae (Houle-Leroy et al. 2003). Beyond this, the MM allele
has many pleiotropic effects in homozygotes, including
a doubling of mass-specific aerobic capacity as compared
with wild-type muscle (Houle-Leroy et al. 2003), altered
fiber type composition in the gastrocnemius (Guderley et al.
2008), altered muscle contractile performance (Syme et al.
2005), an increase in size of their ventricles, liver, and spleen
(Garland et al. 2002; Swallow et al. 2005), and longer and
thinner hindlimb bones (Kelly et al. 2006). Many of these
effects seem conducive to the support of endurance running
(Garland 2003; Guderley et al. 2006; Rezende et al. 2006).
To date, clearly deleterious consequences of the MM allele
have not been reported.
Although the physiological consequences of MM are
becoming well understood, the nature of the underlying
mutation has not been characterized. Identification of the
MM gene, and how variation within that gene leads to the
MM phenotype, would be important for understanding both
normal and abnormal muscle development in mammalian
species. We recently described the creation and phenotypic
characterization of a population suitable for mapping the
genomic location of the MM gene (Hannon et al. 2008). We
crossed females from the HR line that is fixed for the MM
679
allele with male C57BL/6J. F1 males were then backcrossed
to the MM parent females. The HR(B6HRF1) backcross
(BC) mice (N 5 404) were dissected, and a 50:50 ratio of
normal to MM phenotype was observed. In this paper, we
report on linkage mapping of MM in this BC population to
a 2.6335-Mb interval on MMU11. This region harbors;100
expressed or predicted genes, many of which have known
roles in muscle development and/or function.
Methods
Development of BC Mapping Population
As described elsewhere (Hannon et al. 2008), 20 C57BL/6J
males (The Jackson Laboratory, Bar Harbor, ME) were
harem mated with each of 3 females from HR line 3, which
is apparently fixed for the MM mutant allele (Syme et al.
2005). Sixty male F1 mice were weaned at 21 days of age. At
approximately 8 weeks of age, they were randomly back-
crossed (one dam with one sire) to the HR line 3 dams, with
the exception that mother–son and aunt–nephew matings
were disallowed. Once dams were visually pregnant, F1
males were removed. The HR(B6HRF1) BC pups were
weaned at 21 days, then all line 3 dams and F1 males were
dissected following Garland et al. (2002) to determine MM
phenotype status (see below).
When BC pups reached approximately 7 weeks of age,
they were given 6 days of wheel access (as in the routine
selective breeding protocol described by Swallow et al.,
1998) and then dissected to determine MM phenotype. For
mice in all 4 groups (C57BL/6J males, HR line 3 females, F1
offspring, and BC offspring), plots of mean triceps surae
muscle mass against body mass allowed unambiguous
identification of MM individuals (Figure 1).
Chromosomal Localization and Fine Mapping of MM
General Methods
Microsatellite marker analysis was performed in 2 overall
steps. An initial genome-wide scan was performed with
sparse genome coverage using 54 BC mice segregating for
MM, to identify the general chromosomal region harboring
the MM gene. This was followed by fine mapping with
dense marker coverage within the MM region using all BC
mice. Microsatellite markers were genotyped as previously
described (Allan et al. 2005). Linkage maps were constructed
using MAP MANAGER QTX (http://www.mapmanager.
org/mmQTX.html). For all linkage estimations, genotypes
for MM were inferred based on phenotypic evidence as
described above. BC mice with MM were designated
mini/mini, whereas mice with no evidence of MM were
designated mini/B6.
Sparse Mapping
Because HR has not been previously genotyped for
microsatellite markers, and is not fully inbred, we initially
tested several markers on each autosome for informative-
ness in the BC. Two or 3 microsatellite markers (total of 48)
across all 19 autosomes were selected for the scan (data not
shown). These were genotyped across a subset of 54 BC
mice having a 50:50 ratio of MM and normal phenotypes
selected across several BC families. A Chi-square test was
used to test for significant (P , 0.05) linkage between
a microsatellite marker and the mutant gene, by examining
deviations from the expectation that 50% of the samples
should have a mini/mini marker genotype and 50% should
have a mini/B6 genotype.
Fine Mapping
Initially, markers D11Mit108, D11Mit260, D11Mit141, and
D11Mit212, all found to be informative in the initial marker
testing, were genotyped across the full BC population of 404
mice, and a linkage map was generated for these 4 markers
and MM. For further fine mapping, additional markers were
tested in the region between 37.0 and 43.8 cM (Table 1).
From this test, an additional 3 markers (D11Mit4,
D11Mit31, and D11Mit90) were selected and genotyped in
the full BC and a new linkage map was generated based on 7
microsatellite markers and MM.
Subsequently, additional informative markers were
genotyped but only in specific BC mice harboring a re-
combination near the estimated linkage position of MM.
New markers were genotyped in the regions between
D11Mit260 (34.4 cM, 61.61 Mb) and D11Mit4 (37.0 cM,
68.42 Mb) and between D11Mit31 (40.0 cM) and D11Mit90
(42.0 cM, 70.31 Mb). When no previously published
markers were available, primers were designed flanking
putative microsatellites identified through BLAST searches
in Ensembl and informative markers were genotyped. This
process was continued until nearly all information on
Figure 1. Relation between triceps surae mass (mean of left
and right) and body mass for HR(B6HRF1) BC mice. The MM
phenotype, characterized by a nearly 50% reduction in muscle
mass, was found in ;50% of BC mice, supporting a single
recessive locus model.
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position (Mb) Phase of mapping
D1mit318 1 18.5 33.84 Sparse mapping
D1mit33 1 81.6 160.34 Sparse mapping
D1mit128 1 36.9 72.57 Sparse mapping
D2mit297 2 29.0 42.46 Sparse mapping
D2mit171 2 98.0 34.34 Sparse mapping
D3mit203 3 11.2 26.84 Sparse mapping
D3mit147 3 79.4 148.41 Sparse mapping
D4mit171 4 6.3 22.41 Sparse mapping
D4mit139 4 28.6 55.26 Sparse mapping
D4mit71 4 61.9 133.34 Sparse mapping
D5mit126 5 20.0 35.80 Sparse mapping
D5mit240 5 59.0 109.52 Sparse mapping
D6mit119 6 25.5 50.81 Sparse mapping
D6mit31 6 38.5 92.67 Sparse mapping
D6mit217 6 60.5 125.27 Sparse mapping
D7mit227 7 16.0 37.37 Sparse mapping
D7mit321 7 48.5 105.05 Sparse mapping
D8mit64 8 16.0 33.90 Sparse mapping
D8mit215 8 59.0 118.38 Sparse mapping
D9mit205 9 18.0 37.11 Sparse mapping
D9mit165 9 38.0 68.53 Sparse mapping
D9mit212 9 61.0 108.54 Sparse mapping
D10mit126 10 21.0 26.73 Sparse mapping
D10mit70 10 59.0 103.54 Sparse mapping
D11mit108 11 18.0 35.86 Sparse mapping and
initial fine mapping
D11mit141 11 27.0 52.96 Initial fine mapping
D11mit260 11 34.4 61.61 Initial fine mapping
D11Mit115 11 37.0 67.45 Tertiary fine mapping
3D 11 — 67.97 Tertiary fine mapping
D11Mit1000a 11 — 68.32 Secondary fine mapping
D11Mit4 11 37.0 68.42 Secondary fine mapping
D11mit60 11 40.0 69.55 Tertiary fine mapping
D11mit30 11 39.8 69.61 Tertiary fine mapping
D11mit29 11 40.0 69.61 Tertiary fine mapping
D11mit31 11 40.0 — Tertiary fine mapping
1F 11 — 70.09 Tertiary fine mapping
1H 11 — 70.09 Tertiary fine mapping
1A 11 — 70.10 Tertiary fine mapping
1B 11 — 70.10 Tertiary fine mapping
D11Mit90 11 42.0 70.31 Secondary fine mapping
D11mit212 11 50.0 88.67 Sparse mapping and
initial fine mapping
D12mit185 12 11.0 27.75 Sparse mapping
D12mit153 12 15.0 35.92 Sparse mapping
D12mit156 12 34.0 80.56 Sparse mapping
D12mit158 12 38.0 83.72 Sparse mapping
D13mit158 13 5.0 49.33 Sparse mapping
D13mit198 13 7.7 35.06 Sparse mapping
D13mit139 13 32.0 51.86 Sparse mapping
D13mit202 13 47.0 91.61 Sparse mapping
D14mit141 14 15.0 47.38 Sparse mapping
D14mit82 14 19.5 53.41 Sparse mapping
D14mit196 14 47.0 — Sparse mapping
D15mit12 15 4.7 31.61 Sparse mapping
D15mit107 15 49.0 84.22 Sparse mapping
D16mit132 16 3.7 — Sparse mapping
D16mit71 16 70.7 97.13 Sparse mapping
D17mit175 17 17.7 — Sparse mapping
D17mit72 17 47.4 79.39 Sparse mapping
D18mit123 18 31.0 56.13 Sparse mapping
D18mit4 18 57.0 84.30 Sparse mapping
D19mit128 19 10.9 17.33 Sparse mapping
D19mit67 19 43.0 44.47 Sparse mapping
D19mit71 19 54.0 59.67 Sparse mapping
a D11Mit1000 is named D17Mit144 in the Ensembl database.
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location of recombinations in the BC was exhausted. A total
of 17 newly designed markers were tested, of which 15
amplified well and 5 were informative (Table 1).
Candidate Gene Sequencing
DNA from C57BL/6J (n 5 1), HR Line 3 mice with MM
(n 5 3), HR Line 6 mice with MM (n 5 3), and HR Line 6
mice without MM (n 5 3) was used to generate polymerase
chain reaction (PCR) products for sequencing of candidate
genes within the fine-mapped MM interval. For sox15,
overlapping PCR products were amplified encompassing the
entire gene plus some flanking sequence (Ensembl coor-
dinates: 69,468,319–69,470,660). For Chrnb1, 11 overlapping
PCR products were amplified to encompass 4959 bp of the
gene including all 11 exons and part of the 5# and 3#





69,598,061; 69,597,174–69,597,674). For rpl26, overlapping
PCR products were amplified representing the entire gene
(Ensembl coordinates: 68,715,068–68,718,035). All PCR
products incorporated 5# and 3#M13 tails and were sequenced




Two microsatellite markers on MMU11 (D11Mit108, 18 cM,
36 Mb and D11Mit212, 50 cM, 89 Mb) were found to be
linked with MM (P,0.01; Table 2) based on genotyping of
54 BC mice. Given that the estimated strength of linkage
between MM and each of these markers was very similar
(Table 2), the position of MM was presumed to be near the
midpoint of the markers at ;35 cM. No markers on other
chromosomes showed significant linkage to MM.
Fine Mapping
Results of initial linkage mapping using MM and 4
microsatellite markers genotyped across the full BC
population are summarized in Table 3. The estimated
positions are given as ranges. MM mapped between markers
D11Mit260 (34.4 cM, 61.6 Mb) and D11Mit212 (50 cM,
88.7 Mb). Location of MM was estimated to be 4.45 cM
distal to D11Mit260 and 9.83 cM proximal to D11Mit212.
After genotyping of 3 additional markers (D11Mit4,
D11Mit31, and D11Mit90), only one (D11Mit90, 42 cM,
70.32 Mb) revealed new recombinations for linkage mapping.
Results of the new mapping including this additional marker
are summarized in Table 4 and Figure 2, showing that the
region harboringMMhad nowbeen effectively reduced to the
interval of 61.6–70.3 Mb. The very tight linkage (0.5 cM)
between MM and D11Mit90 provided evidence that MM
was likely near the distal edge of this interval.
For further fine mapping of the MM mutation, only mice
with recombinations between MM and D11Mit260 on the
proximal end (n 5 18) or D11Mit90 on the distal end (n 5 2)
were genotyped. Given that no new estimations of linkage
would be feasible, only physical locationswere used at this point
to guide selection and/or design of additional microsatellite
markers. New genotypingwithin this region revealed additional
recombinations, helping to further refine the localization of
MM (Table 5), with new boundaries ofD11Mit115 (67.453Mb)
and the newly designedmarker 1F (70.0865). Having exhausted
recombinations in this BC population, MM was localized to
this 2.6335-Mb region, which harbors ;100 genes (Table 6;
NCBI Build 37.1 [February, 2008]).
Candidate Gene Sequencing
Three genes within the 2.6335-Mb region harboring MM
were selected for sequencing based on having well-
characterized roles in muscle development. For sox15, no
genetic variation was observed across the entire gene
sequence between any of the samples. For chrnb1, 2 single
nucleotide polymorphisms and a 3-bp deletion (GGA/-)
were observed between C57BL/6J and HR mice within the
3# UTR (data not shown). However, none of the sequence
variants found within chrnb1 correlated with the MM
phenotype within HR mice. For rpl26, many polymorphisms






MM mice Normal mice
Chi squareMini/mini Mini/B6 Mini/mini Mini/B6
D11Mit108 18 35.86 24 6 4 20 9.48
D11Mit212 50 88.67 23 6 4 21 10.7


















MGD, mouse genome database.
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were found between C57BL/6J and HR mice (data not
shown), but again, none of this genetic variation segregated in
a manner that provided evidence for being causal for MM.
Discussion
Mapping and subsequent identification of spontaneous
mutations with major phenotypic effect in mice have played
a significant role in furthering our understanding of many
physiological processes. These include growth (e.g., growth
hormone–releasing hormone receptor; Godfrey et al. 1993),
obesity (e.g., leptin; Zhang et al. 1994), and reproduction
(e.g., gonadotropin-releasing hormone; Mason et al. 1986).
Spontaneous mutations in genes regulating muscle de-
velopment have also been identified. For example, the
‘‘compact’’ mutation causing hypermuscularity in mice
(Varga et al. 1997) was subsequently identified as a deletion
in myostatin (mstn) (Szabó et al. 1998), a finding that was
driven by the discovery that muscles of myostatin knockout
mice weigh 2–3 times more than those of wild-type animals
(McPherron et al. 1997). A second example is the ‘‘high-
growth’’ mutation, which was first observed because it
caused a 30–50% increase in postweaning growth rate of
mice (Bradford and Famula 1984). The underlying mutation
was later identified as a ;500-kb deletion of a region
containing the gene cytokine signaling 2 (Socs2), a member of
a family of regulators of cytokine signal transduction
(Horvat and Medrano 2001).
In this study, we have mapped the recessive MM
mutation, which causes most hindlimb muscles to have
markedly reduced mass, to a 2.6335-Mb interval on
MMU11. Effects of this MM mutation were originally
observed in 2 of 4 replicate lines during the course of long-
term selective breeding for high levels of voluntary wheel
running and in 1 of 4 control (nonselected) lines (Garland
et al. 2002). Analyses of data from the first 22 generations of
the selection experiment indicated that the mutant allele was
present at a frequency of approximately 7% in the base



















MGD, mouse genome database.
Figure 2. Initial linkage map of the MM region after
genotyping of 6 markers on MMU11 in the full HR(B6HRF1)
BC population.
Table 5. Genotypic matrix for further fine mapping of MM
using 20 informative BC mice
Mouse
ID
D11Mit260 D11Mit115 MM 1F D11Mit90
61.609 Mb 67.453 Mb — 70.0865 Mb 70.313 Mb
4302 H R R — R
4482 H R R — R
4471 H R R — R
4472 H R R — R
4081 H R R — R
4239 — R R — R
4196 H R R — R
4238 R H H — H
4427 R H H — H
4276 R H H — H
4269 R H H — H
4292 R H H — H
4279 R H H — H
4152 R H H — H
4404 R H H — H
4268 R H H — H
4197 R R H — H
4086 H H R — R
4199 R — R H H
4344 H — H H R




Table 6. Expressed and predicted genes within the 2.6335 Mb MMU11 region harboring MM
Symbol Start base pair Stop base pair Description
Gas7 67,416,607 67,498,461 Growth arrest specific 7
Rcvrn 67,500,799 67,516,835 Recoverin
Glp2r 67,519,932 67,584,655 Glucagons-like peptide 2 receptor
LOC544792 67,588,110 67,603,400 Similar to germ cell associated 1 (predicted)
Dhrs7c 67,611,790 67,629,507 Dehydrogenase/reductase (family) member 7C
LOC100041899 67,651,191 67,657,281 Hypothetical protein LOC100041899
Usp43 67,668,025 67,735,655 Ubiquitin-specific peptidase 43
Wdr16 67,738,308 67,779,144 WD repeat domain 16
Stx8 67,779,985 68,020,650 Syntaxin 8
Ntn1 68,022,866 68,200,328 Netrin 1
Pik3r5 68,245,627 68,311,348 Phosphoinositide-3-kinase, regulatory subunit 5, p101
BB220380 68,316,521 68366200 Expressed sequence BB220380
BC024997 68,369,688 68,371,747 cDNA sequence BC024997
Ccdc42 68,407,557 68,411,456 Coiled-coil domain containing 42
Myh10 68,505,417 68,630,126 Myosin, heavy polypeptide 10, nonmuscle
Ndel1 68,634,936 68,666,564 Nuclear distribution gene E-like homolog 1 (A. nidulans)
9930039A11Rik 68,702,055 68,708,517 RIKEN cDNA 9930039A11 gene
Rpl26 68,715,068 68,718,036 Ribosomal protein L26
Odf4 68,735,337 68,740,551 Outer dense fiber of sperm tails 4
Arhgef15 68,756,656 68,770,360 Rho guanine nucleotide exchange factor 15
Slc25a35 68,781,633 68,786,017 Solute carrier family 25, member 35
2400006H24Rik 68,785,989 68,787322 RIKEN cDNA 2400006H24 gene
Pfas 68,798,671 68,821,962 Phosphoribosylformylglycinamidine synthase (amidotransferase)
1500010J02Rik 68,829,615 68,849,972 RIKEN cDNA 1500010J02 gene
Aurkb 68,859,145 68,865,164 Aurora kinase B
2310047M10Rik 68,873,277 68,875,078 RIKEN cDNA 2310047M10 gene
Tmem107 68,884,311 68,886,794 Transmembrane protein 107
Vamp2 68,902,030 68,905,883 Vesicle-associated membrane protein 2
Per1 68,912,451 68,923,462 Period homolog 1 (Drosophila)
Hes7 68,933,955 68,936,761 Hairy and enhancer of split 7 (Drosophila)
Aloxe3 68,939,879 68,962,616 Arachidonate lipoxygenase 3
Alox12b 68,970,574 68,983,293 Arachidonate 12-lipoxygenase, 12R type
Alox8 68,997,387 69,011,341 Arachidonate 8-lipoxygenase
Gucy2e 69,036,537 69,050,147 Guanylate cyclase 2e
Cntrob 69,112,998 69,137,277 Centrobin, centrosomal BRCA2-interacting protein
Trappc1 69,137,482 69,139,295 Trafficking protein particle complex 1
Kcnab3 69,139,760 69,146,543 Potassium voltage–gated channel, shaker-related subfamily, beta member 3
A030009H04Rik 69,154,319 69,156,143 RIKEN cDNA A030009H04 gene
Chd3 69,156,775 69,182,928 Chromodomain helicase DNA-binding protein 3
Cyb5d1 69,207,114 69,208,848 Cytochrome b5 domain containing 1
Lsmd1 69,209,293 69,210,173 LSM domain containing 1
Tmem88 69,210,021 69,211,736 Transmembrane protein 88
Jmjd3 69,212,010 69,227,177 Jumonji domain containing 3
Dnahc2 69,234,311 69,362,610 Dynein, axonemal, heavy chain 2
Efnb3 69,367,627 69,373,680 Ephrin B3
Wdr79 69,375,256 69,392,826 WD repeat domain 79
LOC100043030 69,387,322 69,387,686 Similar to ribosomal protein S27 (metallopanstimulin 1)
Trp53 69,393,483 69,405,373 Transformation-related protein 53
Atp1b2 69,413,252 69,419,462 ATPase, Naþ/Kþ transporting, beta 2 polypeptide
Shbg 69,428,318 69,431,370 Sex hormone–binding globulin
Sat2 69,435,611 69,437,371 Spermidine/spermine N1-acetyl transferase 2
LOC382532 69,444,405 69,444,814 Similar to ribosomal protein S15a
Fxr2 69,446,473 69,466,799 Fragile X mental retardation, autosomal homolog 2
Sox15 69,468,875 69,470,123 SRY-box–containing gene 15
Mpdu1 69,470,206 69,476,144 Mannose-P-dolichol utilization defect 1
Cd68 69,477,873 69,479,564 CD68 antigen
Eif4a1 69,480,441 69,485,817 Eukaryotic translation initiation factor 4A1
Senp3 69,486,620 69,495,348 SUMO/sentrin-specific peptidase 3
Tnfsf13 69,496,079 69,499,056 Tumor necrosis factor (ligand) superfamily, member 13
Tnfsf12-tnfsf13 69,496,079 69,509,499 Tumor necrosis factor (ligand) superfamily, member 12-member 13
Tnfsf12 69,499,850 69,509,256 Tumor necrosis factor (ligand) superfamily, member 12
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population (outbred Hsd:ICR mice). It is intriguing that
both the compact and high-growth mutations were also
originally discovered during the course of long-term
selection experiments, for increased carcass protein content
(Varga et al. 1997) and rapid weight gain (Bradford and
Famula 1984), respectively. It is not known if the compact
mutation was segregating in the base population prior to
selection. For high growth, the mutation arose spontane-
ously after more than 20 generations of selection. The
appearance of major mutations affecting a trait under
selection has been documented many other times, as
discussed by Varga et al. (1997). The strong selection
intensity placed on quantitative traits during artificial
selection experiments is well suited to take advantage of
preexisting genetic variation in the base population or newly
created genetic variation during the selection experiment,
arising due to spontaneous mutations with major pheno-
typic effect.
Although our mapping efforts have succeeded in
localizing MM to a reasonably small genomic interval, the
goal of identifying the genetic variation responsible for the
MM phenotype remains a formidable challenge. Mouse
chromosome 11 is gene rich, with an average of 14 genes
per Mb compared with the genome-wide average of 6.5.
However, the 2.6335-Mb MM interval on MMU11 is
extremely dense with genes, harboring 102 expressed and
predicted genes (NCBI Build 37.1; February, 2008).
Furthermore, many of the genes within this region represent
viable candidates based on known physiological roles in
muscle development. For example, SRY-box containing
Table 6. Continued
Symbol Start base pair Stop base pair Description
LOC100041994 69,543,497 69,545,211 Hypothetical protein LOC100041994
Polr2a 69,547,912 69,571,725 Polymerase (RNA) II (DNA directed) polypeptide A
Amac1 69,573,386 69,575,346 Acyl-malonyl–condensing enzyme 1
Zbtb4 69,588,908 69,593,175 Zinc finger and BTB domain containing 4
Chrnb1 69,597,539 69,609,445 Cholinergic receptor, nicotinic, beta polypeptide 1 (muscle)
Fgf11 69,611,704 69,615,127 Fibroblast growth factor 11
Tmem102 69,617,105 69,619,126 Transmembrane protein 102
4933402P03Rik 69,630,068 69,631,942 RIKEN cDNA 4933402P03 gene
1700095G12Rik 69,634,373 69,635,667 RIKEN cDNA 1700095G12 gene
Nlgn2 69,636,625 69,648,351 Neuroligin 2
1810027O10Rik 69,652,027 69,653,060 RIKEN cDNA 1810027O10 gene
Plscr3 69,660,178 69,665,560 Phospholipid scramblase 3
Tnk1 69,664,601 69,672,219 Tyrosine kinase, nonreceptor, 1
LOC432576 69,690,186 69,691,607 Hypothetical LOC432576
Kctd11 69,691,179 69,694,908 Potassium channel tetramerisation domain containing 11
Centb1 69,695,069 69,709,041 Centaurin, beta 1
2810408A11Rik 69,710,860 69,714,488 RIKEN cDNA 2810408A11 gene
0610025P10Rik 69,715,393 69,727,322 RIKEN cDNA 0610025P10 gene
Gps2 69,727,694 69,730,093 G-protein pathway suppressor 2
Eif5a 69,730,224 69,734,843 Eukaryotic translation initiation factor 5A
Ybx2 69,749,401 69,755,101 Y-box protein 2
Slc2a4 69,755,788 69,761,692 Solute carrier family 2 (facilitated glucose transporter), member 4
LOC668442 69,764,300 69,764,986 Similar to Cofilin-1 (Cofilin, nonmuscle isoform)
Cldn7 69,779,003 69,781,380 Claudin 7
Rai12 69,781,726 69,794,012 Retinoic acid induced 12
Dullard 6,9794,670 69,804,103 Dullard homolog (Xenopus laevis)
Gabarap 69,804,872 69,808,448 Gamma-aminobutyric acid receptor–associated protein
Phf23 69,809,279 69,813,418 PHD finger protein 23
Dvl2 69,814,128 69,823,611 Disheveled 2, dsh homolog (Drosophila)
Acadvl 69,823,694 69,828,909 Acyl-Coenzyme A dehydrogenase, very long chain
Dlg4 69,832,366 69,858,270 Discs, large homolog 4 (Drosophila)
Asgr1 69,867,871 69,871,396 Asialoglycoprotein receptor 1
Asgr2 69,906,146 69,919,689 Asialoglycoprotein receptor 2
Mgl2 69,943,859 69,951,044 Macrophage galactose N-acetyl-galactosamine–specific lectin 2
Mgl1 69,980,276 69,984,336 Macrophage galactose N-acetyl-galactosamine–specific lectin 1
Slc16a11 70,027,582 70,029,915 Solute carrier family 16 (monocarboxylic acid transporters), member 11
Slc16a13 70,030,294 70,034,496 Solute carrier family 16 (monocarboxylic acid transporters), member 13
Bcl6b 70,037,630 70,043,223 B-cell CLL/lymphoma 6, member B
0610010K14Rik 70,048,710 70,051,416 RIKEN cDNA 0610010K14 gene
D11Bwg0434e 70,051,628 70,053,348 DNA segment, Chr 11, Brigham and Women’s Genetics 0434 expressed
Alox12 70,054,957 70,068,843 Arachidonate 12-lipoxygenase
Data retrieved from NCBI Build 37.1 (February, 2008).
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gene 15 (sox15) plays a role determining the early myogenic
cell lineages during mouse skeletal muscle development (Lee
et al. 2004). Mutations within cholinergic receptor, nicotinic,
beta polypeptide 1 (chrnb1) have been shown to cause
congenital myasthenic syndromes in humans (Quiram et al.
1999), as have mutations within the epsilon subunit (chrne),
which falls just;500 kb distal to the MM region. Ribosomal
protein L26 (rpl26) is very strongly upregulated (;35-fold
increase) in satellite cells during muscle regeneration
(Kardon G, personal communication). Although we found
no causal sequence variation within these 3 genes, additional
polymorphisms could exist in regions outside of those in
our sequencing design.
In addition to these 3 candidate genes, many of the other
;100 genes in the MM region are expressed in muscle, and
the Acadvl, Myh10, Slc2a4, and Trp53 genes all have effects on
muscle when genetically modified (Mouse Genome In-
formatics database; February, 2008). Many of the genes in
this region still have unknown function and may be involved
in muscle development or regulation. Further, there are
several microRNA genes (miR-324-3P, miR-497, miR-195) in
the MM region that target genes with phenoconnectivity to
muscle physiology. Finally, the genetic variation underlying
MM could be acting via trans-regulatory effects on other
genes with physiological roles in muscle development,
including excellent candidates that are just ;500 kb
proximal to the MM interval (e.g., myosin, heavy poly-
peptide 3, skeletal muscle, embryonic; myh3). Disruption of
myh3 results in reduced muscle mass similar to what is
observed in MM (Acakpo-Satchivi et al. 1997; Allen et al.
2001) and a missense mutation in this gene results in
autosomal dominant myopathy in humans (Martinsson et al.
2000). A polymorphism within the MM region could have
regulatory effects on this closely adjacent gene or on
unlinked genes that regulate muscle.
In summary, a recessive MM mutation causing reduced
hindlimb muscle mass in mice has been mapped to a 2.6335-
Mb interval on MMU11 containing ;100 genes, many of
which have known roles in muscle development. Identifi-
cation of the genetic variation that underlies MM could
potentially be very important in understanding both normal
muscle function and disregulation of muscle physiology
leading to disease. However, finding the DNA polymor-
phisms that cause MM will be very challenging given the
gene density and complexity of the mapped region.
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